- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 263/60 - Naphthoxazoles; Hydrogenated naphthoxazoles
Patent holdings for IPC class C07D 263/60
Total number of patents in this class: 44
10-year publication summary
3
|
2
|
5
|
1
|
3
|
1
|
2
|
5
|
3
|
1
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Dana-Farber Cancer Institute, Inc. | 2455 |
4 |
LG Chem, Ltd. | 17205 |
3 |
Universitat de Valencia | 207 |
3 |
Bayer Cropscience AG | 2241 |
2 |
FUJIFILM Corporation | 27102 |
2 |
Biotix, Inc. | 182 |
2 |
The Brigham and Women's Hospital, Inc. | 2087 |
2 |
Rohm and Haas Electronic Materials Korea Ltd. | 546 |
2 |
Huen Co.,Ltd. | 5 |
2 |
Klotho Sciences | 5 |
2 |
Samsung Display Co., Ltd. | 30585 |
1 |
Boehringer Ingelheim International GmbH | 4629 |
1 |
Chevron Oronite Company LLC | 551 |
1 |
Commissariat à l'énergie atomique et aux energies alternatives | 10525 |
1 |
JSR Corporation | 2476 |
1 |
Adeka Corporation | 1333 |
1 |
China Pharmaceutical University | 236 |
1 |
Enanta Pharmaceuticals, Inc. | 420 |
1 |
Irm LLC | 215 |
1 |
Presidio Pharmaceuticals, Inc. | 18 |
1 |
Other owners | 10 |